Researchers in Germany report an advance toward the much awaited era in which scientists will discover and design drugs for cancer, arthritis, AIDS and other diseases almost entirely on the computer, instead of relying on the trial-and-error methods of the past. The new method involves using computers to analyze the chemical structures of potential drugs and pinpoint the most promising candidates.